{"id":19410,"date":"2022-05-13T07:56:40","date_gmt":"2022-05-13T14:56:40","guid":{"rendered":"https:\/\/marketdepth.com\/?p=19410"},"modified":"2022-05-13T07:56:41","modified_gmt":"2022-05-13T14:56:41","slug":"polarityte-reports-fda-designation-granted-to-skinte","status":"publish","type":"post","link":"https:\/\/marketdepth.com\/polarityte-reports-fda-designation-granted-to-skinte\/","title":{"rendered":"PolarityTE Reports FDA Designation Granted to SkinTE"},"content":{"rendered":"\n

PolarityTE, Inc. (NASDAQ: PTE) has reported<\/a> that the U.S. Food and Drug Administration has granted a Regenerative Medicine Advanced Therapy designation to SkinTE under the Company\u2019s open IND.\u00a0 RMAT is a dedicated program that is designed to expedited drug development and review processes for regenerative medicine products, which include human cellular and tissue based therapies.\u00a0\u00a0<\/p>\n\n\n\n

“FDA granting our request for an RMAT designation for SkinTE validates not only the strength of the preliminary clinical evidence we have developed to date but also demonstrates the seriousness of the conditions that we seek to treat and the substantial nature of the unmet needs among the patient populations that we aim to serve.\u00a0 We were pleased to receive this news from the FDA nearly two weeks in advance of the 60-day time period that the Agency has to make such decisions. \u00a0The Agency has offered\u2014and we look forward to capitalizing upon\u2014a multidisciplinary, comprehensive discussion between PolarityTE and the FDA regarding the SkinTE development program, including planned clinical trials and plans for expediting the manufacturing development strategy. \u00a0We are eager to work closely with the Agency to identify potential means to accelerate our development program and help bring a much-needed potential new treatment to patients suffering from substantial unmet medical needs.”<\/p>Richard Hague, Chief Executive Officer<\/cite><\/blockquote>\n","protected":false},"excerpt":{"rendered":"PolarityTE, Inc. (NASDAQ: PTE) has reported that the U.S. Food and Drug Administration has granted a Regenerative Medicine Advanced Therapy designation to SkinTE under the Company\u2019s open IND.\u00a0 RMAT is a dedicated program that is designed to expedited drug development and review processes for regenerative medicine products, which include human cellular and tissue based therapies.\u00a0\u00a0… View Article<\/a>","protected":false},"author":3,"featured_media":18024,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":0,"footnotes":""},"categories":[9,17,8,11,16],"tags":[],"acf":[],"yoast_head":"\nPolarityTE Reports FDA Designation Granted to SkinTE - MarketDepth<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/marketdepth.com\/polarityte-reports-fda-designation-granted-to-skinte\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PolarityTE Reports FDA Designation Granted to SkinTE - MarketDepth\" \/>\n<meta property=\"og:description\" content=\"PolarityTE, Inc. (NASDAQ: PTE) has reported that the U.S. Food and Drug Administration has granted a Regenerative Medicine Advanced Therapy designation to SkinTE under the Company\u2019s open IND.\u00a0 RMAT is a dedicated program that is designed to expedited drug development and review processes for regenerative medicine products, which include human cellular and tissue based therapies.\u00a0\u00a0... View Article\" \/>\n<meta property=\"og:url\" content=\"https:\/\/marketdepth.com\/polarityte-reports-fda-designation-granted-to-skinte\/\" \/>\n<meta property=\"og:site_name\" content=\"MarketDepth\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/marketdepthnews\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-13T14:56:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-05-13T14:56:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/11\/VivosTherapeuticsFDAApproval.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"MarketDepth\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MarketDepthNews\" \/>\n<meta name=\"twitter:site\" content=\"@MarketDepthNews\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"MarketDepth\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/marketdepth.com\/polarityte-reports-fda-designation-granted-to-skinte\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/marketdepth.com\/polarityte-reports-fda-designation-granted-to-skinte\/\"},\"author\":{\"name\":\"MarketDepth\",\"@id\":\"https:\/\/marketdepth.com\/#\/schema\/person\/1c07fd6f269e57bf07013b63d7245f69\"},\"headline\":\"PolarityTE Reports FDA Designation Granted to SkinTE\",\"datePublished\":\"2022-05-13T14:56:40+00:00\",\"dateModified\":\"2022-05-13T14:56:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/marketdepth.com\/polarityte-reports-fda-designation-granted-to-skinte\/\"},\"wordCount\":223,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/marketdepth.com\/#organization\"},\"articleSection\":[\"Biotechnology\",\"Headlines\",\"Healthcare\",\"Investing\",\"What's Hot\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/marketdepth.com\/polarityte-reports-fda-designation-granted-to-skinte\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/marketdepth.com\/polarityte-reports-fda-designation-granted-to-skinte\/\",\"url\":\"https:\/\/marketdepth.com\/polarityte-reports-fda-designation-granted-to-skinte\/\",\"name\":\"PolarityTE Reports FDA Designation Granted to SkinTE - MarketDepth\",\"isPartOf\":{\"@id\":\"https:\/\/marketdepth.com\/#website\"},\"datePublished\":\"2022-05-13T14:56:40+00:00\",\"dateModified\":\"2022-05-13T14:56:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/marketdepth.com\/polarityte-reports-fda-designation-granted-to-skinte\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/marketdepth.com\/polarityte-reports-fda-designation-granted-to-skinte\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/marketdepth.com\/polarityte-reports-fda-designation-granted-to-skinte\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/marketdepth.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PolarityTE Reports FDA Designation Granted to SkinTE\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/marketdepth.com\/#website\",\"url\":\"https:\/\/marketdepth.com\/\",\"name\":\"MarketDepth\",\"description\":\"Stock Market News & Headlines\",\"publisher\":{\"@id\":\"https:\/\/marketdepth.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/marketdepth.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/marketdepth.com\/#organization\",\"name\":\"MarketDepth\",\"url\":\"https:\/\/marketdepth.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/marketdepth.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/05\/MarketDepth-Placeholder-1.jpg\",\"contentUrl\":\"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/05\/MarketDepth-Placeholder-1.jpg\",\"width\":1500,\"height\":1000,\"caption\":\"MarketDepth\"},\"image\":{\"@id\":\"https:\/\/marketdepth.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/marketdepthnews\",\"https:\/\/twitter.com\/MarketDepthNews\",\"https:\/\/www.instagram.com\/marketdepth\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/marketdepth.com\/#\/schema\/person\/1c07fd6f269e57bf07013b63d7245f69\",\"name\":\"MarketDepth\",\"url\":\"https:\/\/marketdepth.com\/author\/3\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PolarityTE Reports FDA Designation Granted to SkinTE - MarketDepth","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/marketdepth.com\/polarityte-reports-fda-designation-granted-to-skinte\/","og_locale":"en_US","og_type":"article","og_title":"PolarityTE Reports FDA Designation Granted to SkinTE - MarketDepth","og_description":"PolarityTE, Inc. (NASDAQ: PTE) has reported that the U.S. Food and Drug Administration has granted a Regenerative Medicine Advanced Therapy designation to SkinTE under the Company\u2019s open IND.\u00a0 RMAT is a dedicated program that is designed to expedited drug development and review processes for regenerative medicine products, which include human cellular and tissue based therapies.\u00a0\u00a0... View Article","og_url":"https:\/\/marketdepth.com\/polarityte-reports-fda-designation-granted-to-skinte\/","og_site_name":"MarketDepth","article_publisher":"https:\/\/www.facebook.com\/marketdepthnews","article_published_time":"2022-05-13T14:56:40+00:00","article_modified_time":"2022-05-13T14:56:41+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/11\/VivosTherapeuticsFDAApproval.jpg","type":"image\/jpeg"}],"author":"MarketDepth","twitter_card":"summary_large_image","twitter_creator":"@MarketDepthNews","twitter_site":"@MarketDepthNews","twitter_misc":{"Written by":"MarketDepth","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/marketdepth.com\/polarityte-reports-fda-designation-granted-to-skinte\/#article","isPartOf":{"@id":"https:\/\/marketdepth.com\/polarityte-reports-fda-designation-granted-to-skinte\/"},"author":{"name":"MarketDepth","@id":"https:\/\/marketdepth.com\/#\/schema\/person\/1c07fd6f269e57bf07013b63d7245f69"},"headline":"PolarityTE Reports FDA Designation Granted to SkinTE","datePublished":"2022-05-13T14:56:40+00:00","dateModified":"2022-05-13T14:56:41+00:00","mainEntityOfPage":{"@id":"https:\/\/marketdepth.com\/polarityte-reports-fda-designation-granted-to-skinte\/"},"wordCount":223,"commentCount":0,"publisher":{"@id":"https:\/\/marketdepth.com\/#organization"},"articleSection":["Biotechnology","Headlines","Healthcare","Investing","What's Hot"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/marketdepth.com\/polarityte-reports-fda-designation-granted-to-skinte\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/marketdepth.com\/polarityte-reports-fda-designation-granted-to-skinte\/","url":"https:\/\/marketdepth.com\/polarityte-reports-fda-designation-granted-to-skinte\/","name":"PolarityTE Reports FDA Designation Granted to SkinTE - MarketDepth","isPartOf":{"@id":"https:\/\/marketdepth.com\/#website"},"datePublished":"2022-05-13T14:56:40+00:00","dateModified":"2022-05-13T14:56:41+00:00","breadcrumb":{"@id":"https:\/\/marketdepth.com\/polarityte-reports-fda-designation-granted-to-skinte\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/marketdepth.com\/polarityte-reports-fda-designation-granted-to-skinte\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/marketdepth.com\/polarityte-reports-fda-designation-granted-to-skinte\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/marketdepth.com\/"},{"@type":"ListItem","position":2,"name":"PolarityTE Reports FDA Designation Granted to SkinTE"}]},{"@type":"WebSite","@id":"https:\/\/marketdepth.com\/#website","url":"https:\/\/marketdepth.com\/","name":"MarketDepth","description":"Stock Market News & Headlines","publisher":{"@id":"https:\/\/marketdepth.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/marketdepth.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/marketdepth.com\/#organization","name":"MarketDepth","url":"https:\/\/marketdepth.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/marketdepth.com\/#\/schema\/logo\/image\/","url":"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/05\/MarketDepth-Placeholder-1.jpg","contentUrl":"https:\/\/marketdepth.com\/wp-content\/uploads\/2021\/05\/MarketDepth-Placeholder-1.jpg","width":1500,"height":1000,"caption":"MarketDepth"},"image":{"@id":"https:\/\/marketdepth.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/marketdepthnews","https:\/\/twitter.com\/MarketDepthNews","https:\/\/www.instagram.com\/marketdepth\/"]},{"@type":"Person","@id":"https:\/\/marketdepth.com\/#\/schema\/person\/1c07fd6f269e57bf07013b63d7245f69","name":"MarketDepth","url":"https:\/\/marketdepth.com\/author\/3\/"}]}},"_links":{"self":[{"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/posts\/19410"}],"collection":[{"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/comments?post=19410"}],"version-history":[{"count":1,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/posts\/19410\/revisions"}],"predecessor-version":[{"id":19411,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/posts\/19410\/revisions\/19411"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/media\/18024"}],"wp:attachment":[{"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/media?parent=19410"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/categories?post=19410"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/marketdepth.com\/wp-json\/wp\/v2\/tags?post=19410"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}